The proposal for the high-quality follow-up vaccination campaign against Measles, Mumps, Rubella, Mumps and Poliomyelitis was presented and unanimously approved, reinforcing the goal of vaccinating 95% or more of the target population and achieving homogeneous coverage per municipality; Continue

0.25 ml per dose intramuscularly in the deltoid muscle; Syringe to be used: 23G x 1 syringe of 1ml; Two doses: The second dose should be administered at least 28 days after the first dose.

Use of inactivated vaccines should be repeated because the efficacy of a single dose is suboptimal efficacy; Complete vaccination schedules at least 2 weeks prior to initiation of immunosuppressive therapies.